Deerfield, Illinois-based healthcare giant Baxter International is partnering with Mayo Clinic to develop a new center of excellence for chronic kidney disease patients—the first action from a five-year partnership agreement inked in 2017.
Announced Tuesday, officials said the renal care center for excellence will serve patients from the management of kidney disease through transplant. The center will be established at the Mayo Clinic Dialysis Center at its Jacksonville, Florida, campus and will integrate Baxter Renal Care Services’ international clinical service model and CKD management program, officials said.
The collaboration will also allow for the trial of potentially new, co-developed products and services, officials said.
RELATED: New kidney care companies intend to make money by keeping patients out of the dialysis chair
In 2017, Baxter and Mayo agreed to a partnership initiative for new research and development projects focused on different therapeutic areas where there are high unmet patient needs.
This announcement comes just days after Baxter announced another collaboration with the University of Southern California Center for Body Computing, saying it seeks to develop digital solutions to help save and sustain lives.
RELATED: National dialysis brands see stock upticks after California veto
”We firmly believe there is a path to better care for kidney patients, which starts by managing the disease before dialysis is required and through simpler, more effective innovations,” said Laura Angelini, general manager of Baxter’s renal care business, in a statement.